Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001338095-14-000045
Filing Date
2014-11-12
Accepted
2014-11-12 16:13:50
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrx0930201410-q.htm 10-Q 621629
2 EXHIBIT 31.1 nrx09302014exhibit311.htm EX-31.1 11826
3 EXHIBIT 31.2 nrx09302014exhibit312.htm EX-31.2 11911
4 EXHIBIT 32 nrx09302014exhibit32.htm EX-32 8338
  Complete submission text file 0001338095-14-000045.txt   4027390

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nrx-20140930.xml EX-101.INS 490253
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrx-20140930.xsd EX-101.SCH 26353
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nrx-20140930_cal.xml EX-101.CAL 46036
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nrx-20140930_def.xml EX-101.DEF 136111
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrx-20140930_lab.xml EX-101.LAB 394018
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrx-20140930_pre.xml EX-101.PRE 223326
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36303 | Film No.: 141214163
SIC: 2834 Pharmaceutical Preparations